Pujani Mukta, Chauhan Varsha, Agarwal Charu, Raychaudhuri Sujata, Singh Kanika
Department of Pathology, ESIC Medical College, Faridabad, Haryana, India.
Diagn Cytopathol. 2019 May;47(5):382-388. doi: 10.1002/dc.24109. Epub 2018 Nov 12.
Fine needle aspiration cytology (FNAC) is the first line investigation for pre-operative diagnosis of salivary gland lesions, but due to its inherent limitations remains a challenge for the cytopathologists. The recently proposed international risk stratification scheme, the Milan System for Reporting Salivary Gland Cytology (MSRSGC) aims to promote and standardise the communication between cytopathologist and clinician thereby improving patient care.
A retrospective study of all salivary gland cytology cases was performed over a 3-year period, reviewed by pathologists and categorised into 1 of the 6 diagnostic categories according to MSRSGC, namely, non-diagnostic, non-neoplastic, atypia of undetermined significance (AUS), benign neoplasm, and salivary gland neoplasm of undetermined significance (SUMP), suspicious for malignancy (SFM), and malignant neoplasm. Cyto- histological correlation was done wherever possible. Risk of malignancy (ROM) was calculated for each diagnostic category.
Out of a total of 150 salivary FNAC cases, histopathology was available for 64 cases. The sensitivity of FNAC was 81.8%, specificity was 100% while the diagnostic accuracy was 96.9%. The positive and negative predictive values were 100% and 96.4% respectively. The ROM for non-diagnostic, non-neoplastic, AUS, benign neoplasm, SUMP, SFM, and malignant categories were 0%, 10%, 50%, 2.5%, 50%, 100%, and 100% respectively.
MSRSGC fulfils the critical need for a uniform, internationally acceptable reporting system with ROM specified for each category. However, large scale multi centre studies need to be conducted before its reliability and validity is proven.
细针穿刺抽吸细胞学检查(FNAC)是唾液腺病变术前诊断的一线检查方法,但由于其固有的局限性,对细胞病理学家来说仍然是一项挑战。最近提出的国际风险分层方案,即米兰唾液腺细胞学报告系统(MSRSGC),旨在促进细胞病理学家和临床医生之间的沟通并使其标准化,从而改善患者护理。
对3年内所有唾液腺细胞学病例进行回顾性研究,由病理学家进行审查,并根据MSRSGC分为6种诊断类别中的1种,即非诊断性、非肿瘤性、意义未明的非典型性(AUS)、良性肿瘤、意义未明的唾液腺肿瘤(SUMP)、可疑恶性(SFM)和恶性肿瘤。尽可能进行细胞组织学相关性分析。计算每个诊断类别的恶性风险(ROM)。
在总共150例唾液腺FNAC病例中,64例有组织病理学结果。FNAC的敏感性为81.8%,特异性为100%,诊断准确性为96.9%。阳性和阴性预测值分别为100%和96.4%。非诊断性、非肿瘤性、AUS、良性肿瘤、SUMP、SFM和恶性类别的ROM分别为0%、10%、50%、2.5%、50%、100%和100%。
MSRSGC满足了对一个统一的、国际上可接受的报告系统的迫切需求,该系统为每个类别指定了ROM。然而,在其可靠性和有效性得到证实之前,需要进行大规模的多中心研究。